Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

Market Cap	29.13B -35.8%
Revenue (ttm)	8.75B -48.5%
Net Income	-14.78B
EPS	-6.18
Shares Out	2.39B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,381,059
Open	12.22
Previous Close	11.37
Day's Range	11.16 - 12.34
52-Week Range	11.07 - 26.00
Beta	0.55
Analysts	Hold
Price Target	19.38 (+59.24%)
Earnings Date	Aug 18, 2026

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vac...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,292
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Analyst Summary

According to 4 analysts, the average rating for 300122 stock is "Hold." The 12-month stock price target is ¥19.38, which is an increase of 59.24% from the latest price.

Price Target

¥19.38

(59.24% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error